
Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy
SHANGHAI, China – January 2, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, ‘Everest’, or the ‘Company’), a […]


















